7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Fractures, Bone D050723 4 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Hypercalciuria D053565 4 associated lipids
Acute Coronary Syndrome D054058 11 associated lipids
No-Reflow Phenomenon D054318 2 associated lipids
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative D054438 1 associated lipids
Hyperphosphatemia D054559 1 associated lipids
Osteophyte D054850 2 associated lipids
Chronic Periodontitis D055113 1 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Bastos MF et al. Hypertension may affect tooth-supporting alveolar bone quality: a study in rats. 2010 J. Periodontol. pmid:20350157
Ohkido I et al. The hypothesis that bone turnover influences FGF23 secretion. 2010 Kidney Int. pmid:20354552
Bartold PM et al. Mechanisms and control of pathologic bone loss in periodontitis. 2010 Periodontol. 2000 pmid:20403105
Nannuru KC et al. Matrix metalloproteinase (MMP)-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor-beta signaling at the tumor-bone interface. 2010 Cancer Res. pmid:20406980
Wu WT et al. The association of serum osteoprotegerin and osteoporosis in postmenopausal hemodialysis patients: a pilot study. 2010 J Womens Health (Larchmt) pmid:20210559
Akat K et al. Calcium metabolism in adults with severe aortic valve stenosis and preserved renal function. 2010 Am. J. Cardiol. pmid:20211333
Canon J et al. Inhibition of RANKL increases the anti-tumor effect of the EGFR inhibitor panitumumab in a murine model of bone metastasis. 2010 Bone pmid:20215062
Verdrengh M et al. RANKL-targeted therapy inhibits bone resorption in experimental Staphylococcus aureus-induced arthritis. 2010 Bone pmid:19879986
Sanchez-Niño MD et al. New paradigms in cell death in human diabetic nephropathy. 2010 Kidney Int. pmid:20703212
Kauther MD et al. Biochemical markers of particle induced osteolysis in C57BL/6 mice. 2010 Clin. Chem. Lab. Med. pmid:20704528
Nuntapornsak A et al. Changes in the mRNA expression of osteoblast-related genes in response to beta(3)-adrenergic agonist in UMR106 cells. 2010 Cell Biochem. Funct. pmid:19827007
Wagner D and Fahrleitner-Pammer A Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: are they of any help? 2010 Wien Med Wochenschr pmid:20714810
Lee JH et al. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal. 2010 Mol. Pharmacol. pmid:19828731
Winzer M et al. Glycitein decreases the generation of murine osteoclasts and increases apoptosis. 2010 Wien Med Wochenschr pmid:20714813
Gruber R Cell biology of osteoimmunology. 2010 Wien Med Wochenschr pmid:20714814
Deng S et al. Regulatory effect of vasoactive intestinal peptide on the balance of Treg and Th17 in collagen-induced arthritis. 2010 Cell. Immunol. pmid:20716449
Kadoglou NP et al. Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization. 2010 J. Vasc. Surg. pmid:19837545
Hu Y et al. Layer-by-layer assembly of β-estradiol loaded mesoporous silica nanoparticles on titanium substrates and its implication for bone homeostasis. 2010 Adv. Mater. Weinheim pmid:20717987
Bae YJ and Kim MH Calcium and Magnesium Supplementation Improves Serum OPG/RANKL in Calcium-Deficient Ovariectomized Rats. 2010 Calcif. Tissue Int. pmid:20811796
Liu YY et al. Circulating Dickkopf-1 and osteoprotegerin in patients with early and longstanding rheumatoid arthritis. 2010 Chin. Med. J. pmid:20819596
Shead EF et al. Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis. 2010 J. Cyst. Fibros. pmid:20006563
Jang S et al. Wogonin inhibits osteoclast formation induced by lipopolysaccharide. 2010 Phytother Res pmid:19998398
Sanuki R et al. Compressive force induces osteoclast differentiation via prostaglandin E(2) production in MC3T3-E1 cells. 2010 Connect. Tissue Res. pmid:20001844
Akiyama T et al. PEDF regulates osteoclasts via osteoprotegerin and RANKL. 2010 Biochem. Biophys. Res. Commun. pmid:19945427
Josson S et al. Tumor-stroma co-evolution in prostate cancer progression and metastasis. 2010 Semin. Cell Dev. Biol. pmid:19948237
Luvizuto ER et al. Histomorphometric analysis and immunolocalization of RANKL and OPG during the alveolar healing process in female ovariectomized rats treated with oestrogen or raloxifene. 2010 Arch. Oral Biol. pmid:19948337
Ikeda K et al. [Animal models for vascular calcification]. 2010 Clin Calcium pmid:21037386
Chollet ME et al. Evidence of a colocalisation of osteoprotegerin (OPG) with von Willebrand factor (VWF) in platelets and megakaryocytes alpha granules. Studies from normal and grey platelets. 2010 Br. J. Haematol. pmid:19958354
Yamaguchi A and Akashi T [Vascular calcification: mutual interaction between bone and blood vessel]. 2010 Clin Calcium pmid:21037387
Yoshida M et al. [Vascular calcification and serum markers]. 2010 Clin Calcium pmid:21037390
Lossdörfer S et al. Anabolic effect of intermittent PTH(1-34) on the local microenvironment during the late phase of periodontal repair in a rat model of tooth root resorption. 2010 Clin Oral Investig pmid:19280233
Ozçaka O et al. Plasma osteoprotegerin levels are decreased in smoker chronic periodontitis patients. 2010 Aust Dent J pmid:21133939
Taveira AT et al. Longitudinal evaluation of hepatic osteodystrophy in children and adolescents with chronic cholestatic liver disease. 2010 Braz. J. Med. Biol. Res. pmid:21049245
Xu DR et al. [Significance of sRANKL/OPG ratio in diagnosis of multiple myeloma bone disease]. 2010 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:20416172
Hamed EA et al. Iron chelation therapy in Upper Egyptian transfusion-dependent pediatric homozygous beta-thalassemia major: impact on serum L-carnitine/free fatty acids, osteoprotegerin/the soluble receptor activator of nuclear factor-kappabeta ligand systems, and bone mineral density. 2010 J. Pediatr. Hematol. Oncol. pmid:20445416
Venuraju SM et al. Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity. 2010 J. Am. Coll. Cardiol. pmid:20447527
Lieb W et al. Biomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortality. 2010 Arterioscler. Thromb. Vasc. Biol. pmid:20448212
Xu M et al. Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice. 2010 Bone pmid:20471507
Oelzner P et al. Combination therapy with dexamethasone and osteoprotegerin protects against arthritis-induced bone alterations in antigen-induced arthritis of the rat. 2010 Inflamm. Res. pmid:20306217
Yue H et al. Role of nuclear unphosphorylated STAT3 in angiotensin II type 1 receptor-induced cardiac hypertrophy. 2010 Cardiovasc. Res. pmid:19696070
Jang JJ et al. Elevated osteoprotegerin is associated with abnormal ankle brachial indices in patients infected with HIV: a cross-sectional study. 2010 J Int AIDS Soc pmid:20307322
Chadipiralla K et al. Osteogenic differentiation of stem cells derived from human periodontal ligaments and pulp of human exfoliated deciduous teeth. 2010 Cell Tissue Res. pmid:20309582
Jørgensen L et al. Bone loss in relation to serum levels of osteoprotegerin and nuclear factor-kappaB ligand: the Tromsø Study. 2010 Osteoporos Int pmid:19701599
Pantsulaia I et al. Association between radiographic hand osteoarthritis and RANKL, OPG and inflammatory markers. 2010 Osteoarthr. Cartil. pmid:20633673
Passeri G et al. Adhesion pattern and growth of primary human osteoblastic cells on five commercially available titanium surfaces. 2010 Clin Oral Implants Res pmid:20636730
Zhu LL et al. [Concentration measurement of the OPG and sRANKL of peripheral blood among normal healthy people]. 2010 Zhongguo Gu Shang pmid:20345025
Tenta R et al. Osteoprotegerin and nuclear factor-kappaB ligand are associated with leptin and adiponectin levels, in apparently healthy women. 2010 J Musculoskelet Neuronal Interact pmid:20516635
Scott JP et al. The effect of training status on the metabolic response of bone to an acute bout of exhaustive treadmill running. 2010 J. Clin. Endocrinol. Metab. pmid:20519353
Bu YH et al. Insulin receptor substrate 1 regulates the cellular differentiation and the matrix metallopeptidase expression of preosteoblastic cells. 2010 J. Endocrinol. pmid:20525764
Yang Y et al. Functional analysis of core binding factor a1 and its relationship with related genes expressed by human periodontal ligament cells exposed to mechanical stress. 2010 Eur J Orthod pmid:20525800
Hope S et al. Osteoprotegerin levels in patients with severe mental disorders. 2010 J Psychiatry Neurosci pmid:20569643
Molines L et al. Charcot's foot: newest findings on its pathophysiology, diagnosis and treatment. 2010 Diabetes Metab. pmid:20570543
Duan XH et al. [The endocrine function of the skeleton]. 2010 Sheng Li Ke Xue Jin Zhan pmid:21416939
Giorgetti AP et al. Cigarette smoke inhalation modulates gene expression in sites of bone healing: a study in rats. 2010 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:20573527
Komosińska-Vassev K et al. [Osteoporosis--pathophysiology and laboratory diagnostic methods]. 2010 Prz. Lek. pmid:21387765
Nybo M et al. Plasma osteoprotegerin concentrations in peripheral sensory neuropathy in Type 1 and Type 2 diabetic patients. 2010 Diabet. Med. pmid:20536491
Mysliwiec J et al. Role of interleukin-6 on RANKL-RANK/osteoprotegerin system in hypothyroid ovariectomized mice. 2010 Folia Histochem. Cytobiol. pmid:21478097
Krause U et al. Pharmaceutical modulation of canonical Wnt signaling in multipotent stromal cells for improved osteoinductive therapy. 2010 Proc. Natl. Acad. Sci. U.S.A. pmid:20150512
Appel H et al. Immunohistochemical analysis of osteoblasts in zygapophyseal joints of patients with ankylosing spondylitis reveal repair mechanisms similar to osteoarthritis. 2010 J. Rheumatol. pmid:20156950
Zdzisińska B et al. Dysregulation of the receptor activator of NF-kappaB ligand and osteoprotegerin production influence the apoptosis of multiple myeloma patients' bone marrow stromal cells co-cultured with myeloma cells. 2010 Arch. Immunol. Ther. Exp. (Warsz.) pmid:20157786
Xu Y et al. Inhibition of bone metastasis from breast carcinoma by rosmarinic acid. 2010 Planta Med. pmid:20157877
Ooi LL et al. Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis. 2010 Cancer Res. pmid:20160035
Pérez-Sayáns M et al. RANK/RANKL/OPG role in distraction osteogenesis. 2010 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:20163972
Buckle CH et al. Targeting RANK/RANKL in the treatment of solid tumours and myeloma. 2010 Curr. Pharm. Des. pmid:20166980
Baekken M et al. Osteoprotegrin and soluble tumor necrosis factor receptor 1 are associated with microalbuminuria in nontreated HIV-infected patients. 2010 J. Acquir. Immune Defic. Syndr. pmid:20190590
Tong PJ et al. [In vitro induction studies of YouGui drink on culture of steroid induced necrosis of femoral head rat osteoblast]. 2010 Zhongguo Gu Shang pmid:20191959
Costa PP et al. Salivary interleukin-6, matrix metalloproteinase-8, and osteoprotegerin in patients with periodontitis and diabetes. 2010 J. Periodontol. pmid:20192865
Dimitrow PP Aortic valve stenosis as a complex inflammatory-hematological-osteogenic disease. 2010 Atherosclerosis pmid:20864109
Leung R et al. Diffuse osteosclerosis complicating hairy cell leukemia. 2010 J. Clin. Oncol. pmid:20194859
Jiang XY et al. A polymorphism near osteoprotegerin gene confer risk of obesity in Uyghurs. 2010 Endocrine pmid:20960157
Enjuanes A et al. The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts. 2010 Endocrine pmid:20960270
Takahashi N et al. [Osteoprotegerin (OPG)]. 2010 Nippon Rinsho pmid:20960766
Yan MZ et al. Raloxifene inhibits bone loss and improves bone strength through an Opg-independent mechanism. 2010 Endocrine pmid:20963556
Loncar G et al. Relationship between RANKL and neuroendocrine activation in elderly males with heart failure. 2010 Endocrine pmid:20963564
Enjuanes A et al. The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts. 2010 Endocrine pmid:20963568
Corallini F et al. TNF-alpha modulates the migratory response of mesenchymal stem cells to TRAIL. 2010 Cell. Mol. Life Sci. pmid:20063037
Zhang YG et al. Effect of negative pressure on human bone marrow mesenchymal stem cells in vitro. 2010 Connect. Tissue Res. pmid:20067412
Kokkotou E et al. Serum correlates of the placebo effect in irritable bowel syndrome. 2010 Neurogastroenterol. Motil. pmid:20028464
Dereka XE et al. RANKL and OPG mRNA level after non-surgical periodontal treatment. 2010 Inflammation pmid:20033478
Kolahi S et al. Fish oil supplementation decreases serum soluble receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio in female patients with rheumatoid arthritis. 2010 Clin. Biochem. pmid:20034487
Benedikt MB et al. 2-methoxyestradiol-mediated anti-tumor effect increases osteoprotegerin expression in osteosarcoma cells. 2010 J. Cell. Biochem. pmid:20082321
Christoforidis A et al. Increased osteoclastic activity as shown by increased sRANK-L/OPG ratio in boys with hemophilia. 2010 Ann. Hematol. pmid:20084381
Ambrus C et al. Bone mineral density in patients on maintenance dialysis. 2010 Int Urol Nephrol pmid:20039127
Petri AD et al. Effects of low-level laser therapy on human osteoblastic cells grown on titanium. 2010 Braz Dent J pmid:21271038
Jensen ED et al. Bone morphogenic protein 2 directly enhances differentiation of murine osteoclast precursors. 2010 J. Cell. Biochem. pmid:20039313
Shiota J et al. [Relationship between coronary and abdominal calcification score, serum osteoprotegerin (OPG), and serum tartrate-resistant acid phosphatase (TRACP) -5b in pre-dialysis CKD patients]. 2010 Nihon Jinzo Gakkai Shi pmid:21254698
Li XD et al. Panax notoginseng saponins potentiate osteogenesis of bone marrow stromal cells by modulating gap junction intercellular communication activities. 2010 Cell. Physiol. Biochem. pmid:21220939
Zhang J et al. [Effect of zoledronic acid on the differentiation and osteoprotegerin production of osteoblasts in rabbit]. 2010 Zhonghua Kou Qiang Yi Xue Za Zhi pmid:21122371
Huang FM et al. Platelet-rich fibrin increases proliferation and differentiation of human dental pulp cells. 2010 J Endod pmid:20850666
Breland UM et al. Inflammatory markers in patients with coronary artery disease with and without inflammatory rheumatic disease. 2010 Rheumatology (Oxford) pmid:20231178
Assmann G et al. Genetic variations in genes encoding RANK, RANKL, and OPG in rheumatoid arthritis: a case-control study. 2010 J. Rheumatol. pmid:20231205
Wang X et al. [Association of serum follicle stimulating hormone with osteoprotegerin, leptin, TGF-β1, and TGF-β2 in women]. 2010 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:21200095
Pino AM et al. Concentration of adipogenic and proinflammatory cytokines in the bone marrow supernatant fluid of osteoporotic women. 2010 J. Bone Miner. Res. pmid:19653807
Masuki H et al. Immunolocalization of DMP1 and sclerostin in the epiphyseal trabecule and diaphyseal cortical bone of osteoprotegerin deficient mice. 2010 Biomed. Res. pmid:21079361
Tawfeek H et al. Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss. 2010 PLoS ONE pmid:20808842
O'Sullivan EP et al. Osteoprotegerin and biomarkers of vascular inflammation in type 2 diabetes. 2010 Diabetes Metab. Res. Rev. pmid:20809534
Klika V and Marsik F A thermodynamic model of bone remodelling: the influence of dynamic loading together with biochemical control. 2010 J Musculoskelet Neuronal Interact pmid:20811146
Tokuyama N and Tanaka S [Cytokines in bone diseases. Genetic disorders of RANKL-RANK-OPG system]. 2010 Clin Calcium pmid:20890036
Hosogane N and Miyamoto T [Cytokines in bone diseases. Osteoprotegerin and juvenile Paget's disease]. 2010 Clin Calcium pmid:20890037
Mesquita M et al. Osteoprotegerin and progression of coronary and aortic calcifications in chronic kidney disease. 2010 Transplant. Proc. pmid:21094794

Table of Content